Trade CADL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Candel Therapeutics, Inc. (CADL) is trading at US$13.17, down 4.21% today as of Aug 28, 13:01 EDT. The company has a market capitalisation of US$1B. Over the past 52 weeks, CADL has traded between US$4.35 and US$14.00. On Syfe you can trade CADL with $0 commission and add it to your watchlist.
| Previous close | US$13.75 |
|---|---|
| Market cap | US$1B |
| 52-week range | US$4.35 – US$14.00 |
| Volume | 1.18M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Year: 2021
--Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target
Jul 13, 11:26 AM · MT Newswires
Candel Therapeutics, Inc. (CADL) stock is trading at US$13.17, -4.21% from the previous close of US$13.75.
The market cap for Candel Therapeutics, Inc. (CADL) stock is approximately US$1B.
The 52-week high for Candel Therapeutics, Inc. (CADL) stock is US$14.00.
The 52-week low for Candel Therapeutics, Inc. (CADL) stock is US$4.35.
Candel Therapeutics, Inc. (CADL) does not currently pay a dividend.
Stay on top of CADL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
